# Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-chimeric-antigen-receptor-car-t-cell-products/cdb5020e-7bcf-4cca-a732-0231b04e3869

> FDA guidance document: Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products. Issue date: January 31, 2024. Get complete insights and analysis.

---

## Details

- Title: Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2024-01-31
- Last Changed: 2024-08-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0404">FDA-2021-D-0404</a>

## Related Documents

- [Considerations for the Development of Dried Plasma Products Intended for Transfusion:   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-dried-plasma-products-intended-for-transfusion-guidance-for-industry/c0c693ab-7392-4bad-b4c9-de122a24ced4)
- [Human Gene Therapy Products Incorporating Human Genome Editing:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-products-incorporating-human-genome-editing-guidance-for-industry/176eb36a-08ad-4533-8261-d03967d6aef6)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)